AAAAAA

   
Results: 1-11 |
Results: 11
Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note (vol 285, pg 788, 2001)
Authors: Handa, K Jacobs, F Longenecker, BM Hakomori, S
Citation: K. Handa et al., Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note (vol 285, pg 788, 2001), BIOC BIOP R, 286(4), 2001, pp. 839-839
Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note
Authors: Handa, K Jacobs, F Longenecker, BM Hakomori, S
Citation: K. Handa et al., Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note, BIOC BIOP R, 285(3), 2001, pp. 788-794
Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer
Authors: Moase, EH Qu, W Ishida, T Gabos, Z Longenecker, BM Zimmermann, GL Ding, L Krantz, M Allen, TM
Citation: Eh. Moase et al., Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer, BBA-BIOMEMB, 1510(1-2), 2001, pp. 43-55
A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells
Authors: Zimmermann, GL Krantz, MJ Kane, KP Longenecker, BM
Citation: Gl. Zimmermann et al., A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells, CANCER IMMU, 49(6), 2000, pp. 305-313
Glycosylations versus conformational preferences of cancer associated mucin core
Authors: Schuman, J Qiu, DX Koganty, RR Longenecker, BM Campbell, AP
Citation: J. Schuman et al., Glycosylations versus conformational preferences of cancer associated mucin core, GLYCOCON J, 17(12), 2000, pp. 835-848
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (R) STn-KLH cancer vaccine
Authors: Holmberg, LA Oparin, DV Gooley, T Lilleby, K Bensinger, W Reddish, MA MacLean, GD Longenecker, BM Sandmaier, BM
Citation: La. Holmberg et al., Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (R) STn-KLH cancer vaccine, BONE MAR TR, 25(12), 2000, pp. 1233-1241
Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine
Authors: Sandmaier, BM Oparin, DV Holmberg, LA Reddish, MA MacLean, GD Longenecker, BM
Citation: Bm. Sandmaier et al., Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine, J IMMUNOTH, 22(1), 1999, pp. 54-66
Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimalantibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells
Authors: Ragupathi, G Howard, L Cappello, S Koganty, RR Qiu, DX Longenecker, BM Reddish, MA Lloyd, KO Livingston, PO
Citation: G. Ragupathi et al., Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimalantibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells, CANCER IMMU, 48(1), 1999, pp. 1-8
Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer
Authors: Hwang, IR Nahm, DH Cho, SN Longenecker, BM Koganty, RR Park, IS
Citation: Ir. Hwang et al., Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer, J CANC RES, 125(10), 1999, pp. 582-587
Rapid induction of primary human CD4(+) and CD8(+) T cell responses against cancer-associated MUC1 peptide epitopes
Authors: Agrawal, B Krantz, MJ Reddish, MA Longenecker, BM
Citation: B. Agrawal et al., Rapid induction of primary human CD4(+) and CD8(+) T cell responses against cancer-associated MUC1 peptide epitopes, INT IMMUNOL, 10(12), 1998, pp. 1907-1916
MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 andMUC1 binding requires six tandem repeats
Authors: Kam, JL Regimbald, LH Hilgers, JHM Hoffman, P Krantz, MJ Longenecker, BM Hugh, JC
Citation: Jl. Kam et al., MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 andMUC1 binding requires six tandem repeats, CANCER RES, 58(23), 1998, pp. 5577-5581
Risultati: 1-11 |